Prosecution Insights
Last updated: October 27, 2026

Kimberly A Aron, USPTO Patent Examiner

Listed by the USPTO as ARON, KIMBERLY A

Tech Center 1600 • Art Units: 1633 1647 1653 1655

This examiner grants 55% of resolved cases

Analysis

ARON, KIMBERLY A works in tech center 1600 and art unit 1633. The record includes 444 resolved cases, a 54.7% allowance rate, and a median of 1282 days to allowance. These figures describe a sizeable examination history with outcomes that are not uniformly favorable, and they place timing among the central considerations for applicants.

The interview lift is 34.3%, indicating a substantial association between interviews and recorded allowance outcomes. The listed companies are Kalivir Immunotherapeutics Inc., The Brigham and Women's Hospital Inc., and University of Washington. The firms are DINSMORE & SHOHL LLP, Entralta, and FOLEY HOAG, LLP (General). Practitioners may consider an early interview supported by focused claim charts, followed by amendments that preserve commercially important scope.

Written from this page's own data; every figure is computed from USPTO records and verified before publication.

Performance Statistics

54.7%
Allow Rate
-5.3% vs TC avg
464
Total Applications
+34.3%
Interview Lift
1282
Avg Prosecution Days
Based on 444 resolved cases, 2023–2026

Rejection Statute Breakdown

4.2%
§101 Eligibility
12.2%
§102 Novelty
40.7%
§103 Obviousness
26.9%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
17618774 RECOMBINANT AD35 VECTORS AND RELATED GENE THERAPY IMPROVEMENTS Final Rejection University of Washington
18741884 SELECTIVE CELL THERAPY FOR THE TREATMENT OF RENAL FAILURE Non-Final OA Wake Forest University Health Sciences
18519972 METHODS AND COMPOSITIONS FOR TREATING METASTATIC BREAST CANCER AND OTHER CANCERS IN THE BRAIN Non-Final OA The Trustees of the University of Pennsylvania
18634364 GENETICALLY MODIFIED NON-HUMAN ANIMALS WITH HUMANIZED IMMUNOGLOBULIN LOCUS Non-Final OA Biocytogen Pharmaceuticals (Beijing) Co., Ltd.

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Who Appears Before This Examiner

Top companies before this examiner

Law firms appearing most often

Frequently Asked Questions

What is examiner Kimberly A Aron's allowance rate?

54.7% of resolved applications examined by Kimberly A Aron were allowed (444 resolved cases), compared with 34.8% across Art Unit 1633 over the last five years.

Does an interview help with examiner Kimberly A Aron?

This examiner's interview lift is +34.3 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.

How long does examiner Kimberly A Aron take to allow a patent?

Applications allowed by Kimberly A Aron took 1,282 days on average from filing to allowance.

Which art unit does examiner Kimberly A Aron work in?

Kimberly A Aron examines applications in Art Unit 1633 in Tech Center 1600 (Biotechnology & Pharmaceuticals).

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month